• Bauman, M.E., Belletrutti, M.J., Bajzar, L., Black, K.L., Kuhle, S., Bauman, M.L. & Massicotte, M.P. (2009) Evaluation of enoxaparin dosing requirements in infants and children: better dosing to achieve therapeutic levels. Thrombosis and Haemostasis, 101, 8692.
  • Bontadelli, J., Moeller, A., Schmugge, M., Schraner, T., Kretschmar, O., Bauersfeld, U., Bernet-Buettiker, V. & Albisetti, M. (2007) Enoxaparin therapy for arterial thrombosis in infants with congenital heart disease. Intensive Care Medicine, 33, 19781984.
  • Burak, C.R., Bowen, M.D. & Barron, T.F. (2003) The use of enoxaparin in children with acute, nonhemorrhagic ischemic stroke. Pediatric Neurology, 29, 295298.
  • Chalmers, E.A. (2006) Epidemiology of venous thromboembolism in neonates and children. Thrombosis Research, 118, 312.
  • Dix, D., Andrew, M., Marzinotto, V., Charpentier, K., Bridge, S., Monagle, P., De Veber, G., Leaker, M., Chan, A.K. & Massicotte, M.P. (2000) The use of low molecular weight heparin in pediatric patients: a prospective cohort study. The Journal of Pediatrics, 136, 439445.
  • Ho, S.H., Wu, J.K., Hamilton, D.P., Dix, D.B. & Wadsworth, L.D. (2004) An assessment of published pediatric dosage guidelines for enoxaparin: a retrospective review. Journal of Pediatric Hematology/Oncology, 26, 561566.
  • Malowany, J.I., Knoppert, D.C., Chan, A.K., Pepelassis, D. & Lee, D.S. (2007) Enoxaparin use in the neonatal intensive care unit: experience over 8 years. Pharmacotherapy, 27, 12631271.
  • Manco-Johnson, M. (2006) How I treat venous thrombosis in children. Blood, 107, 2129.
  • Massicotte, P., Adams, M., Marzinotto, V., Brooker, L.A. & Andrew, M. (1996) Low-molecular-weight heparin in pediatric patients with thrombotic disease: a dose finding study. Journal of Pediatrics, 128, 313318.
  • Massicotte, P., Julian, J., Gent, M., Shields, K., Marzinotto, V., Szechtmanb, B., Chan, A.K. & Andrew, M. (2003) An open-label randomized controlled trial of low molecular weight heparin for the prevention of central venous line-related thrombotic complications in children: the PROTEKT trial. Thrombosis Research, 109, 101108.
  • McCusker, P.J., Seifert, B.W. & Israels, S.J. (2003) Higher doses of enoxaparin are required to achieve therapeutic heparin (aXa) levels in neonates (NBs) with venous thromboembolic disease (VTE). Blood, 102, 1155.
  • Michaels, L.A., Gurian, M., Hegyi, T. & Drachtman, R.A. (2004) Low molecular weight heparin in the treatment of venous and arterial thromboses in the premature infant. Pediatrics, 114, 703707.
  • Monagle, P., Chalmers, E., Chan, A., DeVeber, G., Kirkham, F., Massicotte, P. & Michelson, A.D. (2008) Antithrombotic therapy in neonates and children. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest, 133, 887S968S.
  • Nohe, N., Flemmer, A., Rümler, R., Praun, M. & Auberger, K. (1999) The low molecular weight heparin dalteparin for prophylaxis and therapy of thrombosis in childhood: a report on 48 cases. European Journal of Pediatrics, 158, S134S139.
  • O’Brien, S.H., Lee, H. & Ritchey, A.K. (2007) Once-daily enoxaparin in pediatric thromboembolism: a dose finding and pharmacodynamics/pharmacokinetics study. Journal of Thrombosis and Haemostasis, 5, 19851987.
  • Punter, F., Seshia, M., Israels, S.J. & Seifert, B.W. (2004) Retrospective analysis of the minimum dosage requirements for enoxaparin in neonates with thromboembolic disease. Blood, 104, Abstract 1770.
  • Punzalan, R.C., Hillery, C.A., Montgomery, R.R., Scott, J.P. & Gill, J.C. (2000) Low-molecular-weight heparin in thrombotic disease in children and adolescents. Journal of Pediatric Hematology Oncology, 22, 137142.
  • Revel-Vilk, S., Sharathkumar, A., Massicotte, P., Marzinotto, V., Daneman, A., Dix, D. & Chan, A. (2004) Natural history of arterial and venous thrombosis in children treated with low molecular weight heparin: a longitudinal study by ultrasound. Journal of Thrombosis and Haemostasis, 2, 4246.
  • Streif, W., Goebel, G., Chan, A. & Massicotte, M.P. (2003) Use of low molecular mass heparin (enoxaparin) in newborn infants: a prospective cohort study of 62 patients. Archives of Disease in Childhood. Fetal and Neonatal Edition, 88, F365F370.